GE installs first series of breakthrough molecular imaging scanners
22 February 2009
GE Healthcare has announced the global installation of the new
Discovery PET/CT 600-series scanners, designed to help enable earlier
detection and accurate monitoring of disease combined with the latest
advancements in molecular imaging technology to explore the development
of future applications.
The first clinical installs will be completed at Miami Baptist
Hospital in Florida, University Hospital of Bichat in Paris, France,
Queensland X-Ray at the Mater Hospital in Brisbane, Australia, Duke
University Medical Center in North Carolina, and Mayo Clinic in
“This first set of installations is a big step forward in the
diagnosis and monitoring of disease,” said Terri Bresenham, newly
appointed vice president and general manager of the company’s global
Molecular Imaging business. “Partnering with clinics in the United
States, Europe and the Asia/Pacific Region, we will be able to reach
more patients globally with the latest advancements in oncology,
neurology, and cardiovascular technologies.”
The new PET/CT platform, from GE Healthcare, was built for physicians
and molecular imaging researchers in mind, based on their need for more
power to explore the potential of PET/CT imaging that includes better
PET quantitative accuracy.
This new line of PET/CT scanners, combine advanced molecular imaging
tools with the large coverage low dose Volume CT helping allow for
earlier diagnosis, more accurate tumour location and better assessment
of how a patient is responding to cancer treatment.
Although mostly for use in oncology, PET/CT can also be used for
assisting the diagnosis of cardiovascular disease and neurological
The new system leverages the high-speed, high-resolution capabilities
of GE’s advanced computed tomography scanner, the LightSpeed VCT. Volume
CT technology, with 40mm of coverage, dramatically reduces CT
acquisition times and CT dose. Static organs can be imaged in as little
as one second, the lung in as little as two seconds and a whole body
trauma could be performed in less than 10 seconds.
“The 64 slice PET/CT with advanced molecular imaging technologies has
the potential to take the ability of PET/CT to an even greater level of
accuracy,” said Hao Vuong, MD, medical director of PET/CT at Miami
GE's next generation of MotionFree imaging technologies are
introduced in the new Discovery 600 series PET/CT, giving clinicians
detailed images even in areas of the body subject to movement caused by
GE's breakthrough MotionFree imaging technologies are integrated with
VUE Point FX, an advanced high-definition reconstruction technique.
Combined, these technologies have the potential to improve small lesion
detection, image quality, and better therapy response monitoring.
By combining the LightSpeed VCT with the breakthrough motion
management capabilities of the Discovery PET system, the new Discovery
PET/CT platform provides the next evolution PET/CT system, bringing
clinically-relevant innovations designed to open doors to new and
advanced procedure possibilities in non-invasive diagnostic imaging.
Bookmark this page